patent/WO-0239996-A3

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0239996-A3

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2656e1f676126b3d73be3511b0a69cf7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c955588ed71813ae7ec904a37de56dcd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09a066f5e11b9ad425a5d55fc56bc3f
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
filingDate	2001-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24245952ba1f01d8f30c7c3d4a0a10b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d88e46f13da043a33b30acc14c400da2
publicationDate	2003-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-0239996-A3
titleOfInvention	Combined therapy against tumors comprising estramustine phosphate and lhrh agonists or antagonists
abstract	A method for treating tumors in a mammal, including humans, in need of such a treatment including administering simultaneously, separately or sequentially to said mammal estramustine phosphate and a LHRH agonist or antagonist, in amounts sufficient to achieve a therapeutically useful effect.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9314527-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561243-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9168216-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841342-B2
priorityDate	2000-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9829105-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5795882-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9829123-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423271027 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422726 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542390 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23615712 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44354963 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259329

Total number of triples: 32.